Amcinonide
Specifications
51022-69-6CAS Number
256-915-2EC Number
[2-[(1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-9,13-dimethyl-16-oxospiro[5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-diene-6,1'-cyclopentane]-8-yl]-2-oxoethyl] acetateIUPAC Name
C28H35FO7Chemical Formula
502.6 g/molMolecular Weight
amcinonide; 51022-69-6; Cyclocort; Amcinonidum; Visderm; amcinonida; CL-34699; Triamcinolonacetatcyclopentanonid; CL 34699; DTXSID6045905; 423W026MA9; NSC-758620; DTXCID4025905; CHEBI:31199; 1,4-Pregnadiene-2,20-dione-16,17-cyclopentylidenedioxy-9-fluoro-11,21-dihydroxy-21-acetate; Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-16,17-(cyclopentylidenebis(oxy))-9-fluoro-11-hydroxy-, (11beta,16alpha)-; 2-[(1'S,2'S,4'R,8'S,9'S,11'S,12'R,13'S)-12'-fluoro-11'-hydroxy-9',13'-dimethyl-16'-oxo-5',7'-dioxaspiro[cyclopentane-1,6'-pentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosane]-14',17'-dien-8'-yl]-2-oxoethyl acetate; 2-((1'S,2'S,4'R,8'S,9'S,11'S,12'R,13'S)-12'-fluoro-11'-hydroxy-9',13'-dimethyl-16'-oxo-5',7'-dioxaspiro(cyclopentane-1,6'-pentacyclo(10.8.0.0^(2,9).0^(4,8).0^(13,18))icosane)-14',17'-dien-8'-yl)-2-oxoethyl acetate; triamcinolone 16,17-cyclopentylidenedioxy-21-acetate; RefChem:57708; D07AC11; 256-915-2; MLS000028656; [2-[(1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-9,13-dimethyl-16-oxospiro[5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-diene-6,1'-cyclopentane]-8-yl]-2-oxoethyl] acetate; 9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with cyclopentanone, 21-acetate; Amcinonido; SMR000058920; [2-[(4R,8S,9S,11S,12R,13S)-12-Fluoro-11-hydroxy-9,13-dimethyl-16-oxospiro[5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-diene-6,1'-cyclopentane]-8-yl]-2-oxoethyl] acetate; C28H35FO7; Amcinonidum [INN-Latin]; Amcinonido [INN-Spanish]; Cyclocort (TN); Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-16,17-[cyclopentylidenebis(oxy)]-9-fluoro-11-hydroxy-, (11.beta.,16.alpha.)-; Amcinonide (JAN/USP/INN); UNII-423W026MA9; NCGC00095071-01; PREGNA-1,4-DIENE-3,20-DIONE, 21-(ACETYLOXY)-16,17-(CYCLOPENTYLIDENEBIS(OXY))-9-FLUORO-11-HYDROXY-, (11.BETA.,16.ALPHA.)-; EINECS 256-915-2; MFCD00213379; Amcinonide [USAN:USP:INN:BAN:JAN]; Amcinonide (Standard); AMCINONIDE [MI]; AMCINONIDE [INN]; AMCINONIDE [JAN]; Opera_ID_1472; AMCINONIDE [USAN]; AMCINONIDE [VANDF]; AMCINONIDE [MART.]; SCHEMBL4720; AMCINONIDE [USP-RS]; AMCINONIDE [WHO-DD]; 19alpha-Fluor-11beta,21-dihydroxy-16alpha,17alpha-(tetramethylen)methylendioxy-1,4-pregnadien-3,20-dion 21-acetat; MLS001146959; MLS001333715; MLS002695893; Amcinonide, analytical standard; GTPL7060; orb1310782; orb3139275; AMCINONIDE [ORANGE BOOK]; CHEMBL1200732; HY-B1197R; MSK2243; AMCINONIDE [USP MONOGRAPH]; GLXC-23125; HMS2235K23; HMS3715D11; HY-B1197; Tox21_111411; EBC-27247; MSK2243-100A; s5671; AKOS015961167; MSK2243-1000A; CCG-221135; CS-4805; DB00288; NSC 758620; NCGC00021193-03; 16alpha,17alpha-(cyclopentane-1,1-diyldioxy)-9-fluoro-11beta-hydroxy-3,20-dioxopregna-1,4-dien-21-yl acetate; AC-13190; DA-60974; MS-29335; CAS-51022-69-6; Amcinonide Solution in Acetonitrile, 100ug/mL; D01387; Amcinonide Solution in Acetonitrile, 1000ug/mL; A484091; EN300-19651692; F979808; SR-01000003161; Q4742041; SR-01000003161-2; BRD-K13960744-001-09-7; Amcinonide, United States Pharmacopeia (USP) Reference Standard; [2-[(1S,2S,4R,8S,9S,11S,12R,13S)-12-fluoro-11-hydroxy-9,13-dimethyl-16-oxo-spiro[5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-diene-6,1'-cyclopentane]-8-yl]-2-oxo-ethyl] acetate; 2-[(4'aS,4'bR,5'S,6'aS,6'bS,9'aR,10'aS,10'bS)-4'b-Fluoro-5'-hydroxy-4'a,6'a-dimethyl-2'-oxo-2',4'a,4'b,5',6',6'a,9'a,10',10'a,10'b,11',12'-dodecahydro-6'bH-spiro[cyclopentane-1,8'-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol]-6'b-yl]-2-oxoethyl acetateSynonyms
